Takeda, Tenjin Sue Lupin For Patent Infringement Of Uric-Acid Drug
This article was originally published in PharmAsia News
Executive Summary
Two Japan-based drug makers, Takeda Pharmaceutical and Tenjin Pharma, have filed a lawsuit against India's Lupin and its U.S. arm, Lupin Pharmaceuticals, for infringing on their patent for Uloric (fabuxostat) for controlling uric acid.